220 related articles for article (PubMed ID: 11675331)
1. Clinical significance of CD38 expression in chronic lymphocytic leukemia.
Del Poeta G; Maurillo L; Venditti A; Buccisano F; Epiceno AM; Capelli G; Tamburini A; Suppo G; Battaglia A; Del Principe MI; Del Moro B; Masi M; Amadori S
Blood; 2001 Nov; 98(9):2633-9. PubMed ID: 11675331
[TBL] [Abstract][Full Text] [Related]
2. Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia.
Morabito F; Mangiola M; Oliva B; Stelitano C; Callea V; Deaglio S; Iacopino P; Brugiatelli M; Malavasi F
Leuk Res; 2001 Nov; 25(11):927-32. PubMed ID: 11597727
[TBL] [Abstract][Full Text] [Related]
3. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia.
Ibrahim S; Keating M; Do KA; O'Brien S; Huh YO; Jilani I; Lerner S; Kantarjian HM; Albitar M
Blood; 2001 Jul; 98(1):181-6. PubMed ID: 11418478
[TBL] [Abstract][Full Text] [Related]
4. Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia.
Heintel D; Schwarzinger I; Chizzali-Bonfadin C; Thalhammer R; Schwarzmeier J; Fritzer-Szekeres M; Weltermann A; Simonitsch I; Lechner K; Jaeger U
Leuk Lymphoma; 2001; 42(6):1315-21. PubMed ID: 11911414
[TBL] [Abstract][Full Text] [Related]
5. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
[TBL] [Abstract][Full Text] [Related]
6. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia.
D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Perla G; Savino L; Carotenuto M
Leuk Lymphoma; 2001 Jun; 42(1-2):109-14. PubMed ID: 11699197
[TBL] [Abstract][Full Text] [Related]
7. CXCR4 expression is associated with survival in familial chronic lymphocytic leukemia, but CD38 expression is not.
Ishibe N; Albitar M; Jilani IB; Goldin LR; Marti GE; Caporaso NE
Blood; 2002 Aug; 100(3):1100-1. PubMed ID: 12150154
[No Abstract] [Full Text] [Related]
8. CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.
Dürig J; Naschar M; Schmücker U; Renzing-Köhler K; Hölter T; Hüttmann A; Dührsen U
Leukemia; 2002 Jan; 16(1):30-5. PubMed ID: 11840260
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia.
Del Principe MI; Del Poeta G; Buccisano F; Maurillo L; Venditti A; Zucchetto A; Marini R; Niscola P; Consalvo MA; Mazzone C; Ottaviani L; Panetta P; Bruno A; Bomben R; Suppo G; Degan M; Gattei V; de Fabritiis P; Cantonetti M; Lo Coco F; Del Principe D; Amadori S
Blood; 2006 Aug; 108(3):853-61. PubMed ID: 16601244
[TBL] [Abstract][Full Text] [Related]
10. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.
Jelinek DF; Tschumper RC; Geyer SM; Bone ND; Dewald GW; Hanson CA; Stenson MJ; Witzig TE; Tefferi A; Kay NE
Br J Haematol; 2001 Dec; 115(4):854-61. PubMed ID: 11843819
[TBL] [Abstract][Full Text] [Related]
11. Conversion of CD38 and/or myeloid-associated marker expression status during the course of B-CLL: association with a change to an aggressive clinical course.
Chang CC; Cleveland RP
Blood; 2002 Aug; 100(3):1106. PubMed ID: 12150158
[No Abstract] [Full Text] [Related]
12. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.
Hamblin TJ; Orchard JA; Ibbotson RE; Davis Z; Thomas PW; Stevenson FK; Oscier DG
Blood; 2002 Feb; 99(3):1023-9. PubMed ID: 11807008
[TBL] [Abstract][Full Text] [Related]
13. Quantification of CD38 expression in B-cell chronic lymphocytic leukemia (B-CLL): a comparison between antibody binding capacity (ABC) and relative median fluorescence (RMF).
Dignum HM; Summerfield GP; Proctor SJ; Mainou-Fowler T
Leuk Lymphoma; 2004 Jun; 45(6):1167-73. PubMed ID: 15359996
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia.
Lai R; O'Brien S; Maushouri T; Rogers A; Kantarjian H; Keating M; Albitar M
Cancer; 2002 Sep; 95(5):1071-5. PubMed ID: 12209693
[TBL] [Abstract][Full Text] [Related]
15. Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukaemia.
Mainou-Fowler T; Dignum H; Taylor PR; Dickinson AM; Saunders PW; Proctor SJ; Summerfield GP
Br J Haematol; 2002 Sep; 118(3):755-61. PubMed ID: 12181042
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil.
Morabito F; Mangiola M; Stelitano C; Deaglio S; Callea V; Malavasi F
Haematologica; 2002 Feb; 87(2):217-8. PubMed ID: 11836173
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
Ibrahim S; Jilani I; O'Brien S; Rogers A; Manshouri T; Giles F; Faderl S; Thomas D; Kantarjian H; Keating M; Albitar M
Cancer; 2003 Apr; 97(8):1914-9. PubMed ID: 12673718
[TBL] [Abstract][Full Text] [Related]
18. The use of CD38 expression by monoclonal B lymphocytes as a prognostic factor in B-cell chronic lymphocytic leukemia.
Boonstra JG; von't Veer MB; Gratama JW
J Biol Regul Homeost Agents; 2004; 18(3-4):340-6. PubMed ID: 15786702
[TBL] [Abstract][Full Text] [Related]
19. [Prognositc value of CD38 cell surface marker in chronic lymphocytic leukemia].
Mhes L; Simon A; Rejtö L; Kiss A; Reményi G; Batár P; Telek B; Udvardy M
Orv Hetil; 2003 Aug; 144(31):1531-5. PubMed ID: 14502867
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD.
Zupo S; Massara R; Dono M; Rossi E; Malavasi F; Cosulich ME; Ferrarini M
Blood; 2000 Feb; 95(4):1199-206. PubMed ID: 10666191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]